Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
61.44 USD | +1.02% |
|
-3.52% | +11.43% |
02/07 | ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets | MT |
02/07 | ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.43% | 119.25Cr | |
+56.89% | 82TCr | |
+39.52% | 63TCr | |
-6.55% | 35TCr | |
+15.99% | 32TCr | |
+7.92% | 30TCr | |
+13.74% | 24TCr | |
+13.83% | 22TCr | |
-0.49% | 22TCr | |
+7.94% | 17TCr |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- Ani Pharmaceuticals Insider Sold Shares Worth $663,000, According to a Recent SEC Filing